Start of the Magnetic Resonance Outcome (MRO) study to evaluate the ClearCoast™ MRI system

Start of the Magnetic Resonance Outcome (MRO) study to evaluate the ClearCoast™ MRI system

The ClearCoast™ MRI system makes it possible to perform precise intraoperative margin evaluation during breast-conserving surgery – often eliminating the need for the patient to undergo a second operation. In the MRO study, launched in June 2021, surgeons are able for the first time to evaluate the tissue margin during the operation. The aim: to reduce the rate of second operations by 80 percent. Read more